Medication info
Ciptorin Tablets 10/20 mg

Ciptorin Tablets 10/20 mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
HLB Pharmaceuticals Co., Ltd.
Appearance
A white to off-white, bilaterally convex, rectangular tablet
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201900016 · Approved 2019.01.03 · Insurance code 647303590

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start with 10/10mg daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Because of an increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Warnings, section 1 of Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, this medicine is not recommended for patients with moderate or severe hepatic impairment (see Precautions for Use, section 5, General Precautions, subsection on patients with abnormal liver function). Use in patients with renal impairment and patients with chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see Precautions for Use, section 5, General Precautions). Use in older adults No dose adjustment is required for older adults. Concomitant use with other medicines (See Precautions for Use, section 6, Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
HLB Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular diseases due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps lower elevated total cholesterol, LDL-cholesterol, apo B protein, and triglycerides in patients with primary hypercholesterolemia and mixed hyperlipidemia, while increasing HDL-cholesterol, the good cholesterol. It is particularly used as an adjunct to other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia, or as an alternate treatment when other therapies are insufficient. This medication should be administered alongside a proper diet, and is used for cases where diet alone cannot effectively control lipid levels. Additionally, it is beneficial as a lipid-regulating medication for patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia. It is crucial to identify and treat underlying causes like diabetes and hypothyroidism before administration if present. This medication is used to improve cholesterol-related lipid levels and reduce the risk of cardiovascular diseases.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start with 10/10mg daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Because of an increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Warnings, section 1 of Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, this medicine is not recommended for patients with moderate or severe hepatic impairment (see Precautions for Use, section 5, General Precautions, subsection on patients with abnormal liver function). Use in patients with renal impairment and patients with chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see Precautions for Use, section 5, General Precautions). Use in older adults No dose adjustment is required for older adults. Concomitant use with other medicines (See Precautions for Use, section 6, Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication is used to lower cholesterol levels in the blood. Muscle pain or weakness may occur during treatment, and if these symptoms develop, immediate consultation with a physician is necessary. Be especially cautious as the risk of muscle problems can increase when taking high doses or certain other medications. This medication may affect liver function, so it should not be taken in patients with liver disease or elevated liver enzyme levels. Moreover, pregnant or breastfeeding women should not take this medication, and those planning to become pregnant should consult a physician. The risk of side effects may increase when taken with medications that inhibit certain enzymes, so any ongoing medications should be fully disclosed to a healthcare provider. Elderly patients or those with impaired kidney function may be more sensitive to side effects, necessitating careful monitoring. Regular liver function tests and muscle-related tests are recommended during administration, and any unusual symptoms should be reported to healthcare professionals immediately. There is no specific antidote in case of overdose, but appropriate treatment based on symptoms is needed. While taking this medication, the intake of certain foods like grapefruit juice should be limited, and attention to drug interactions with other medications is important.

Side effects

  • Headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
  • abdominal pain
  • viral infection
  • pharyngitis
Show 102 more
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • increased creatine phosphokinase
  • myopathy
  • rhabdomyolysis
  • elevated liver amino-transferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reactions with systemic symptoms
  • erythema multiforme
  • liver damage
  • weakness
  • cataracts
  • constipation
  • dyspepsia
  • flatulence
  • vomiting
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • dysgeusia
  • oculomotor disturbances
  • facial paresis
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • nightmares
  • cognitive impairment
  • interstitial lung disease
  • angioedema
  • lupus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • increased ALP
  • increased γ-GT
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • increased HbA1c
  • increased fasting blood glucose
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. To maintain its effectiveness, it is advisable to store it at room temperature between 1 degree Celsius and 30 degrees Celsius.

Appearance and packaging

Appearance

A white to off-white, bilaterally convex, rectangular tablet

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.